| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 31.72B | — |
| Operating expense | — | — |
| Net income | 3.18B | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MFY.F returned -21.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -188.9% |
| 1 year | -21.8% |
| 5 years | +213.9% |
| 10 years | -629498414.9% |
| All-time high | €45.96 (Feb 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in MFY.F would be worth today ›Yes. Mochida Pharmaceutical Co., Ltd. paid 2 dividends over the past 12 months. The most recent was €0.22 per share on Mar 30, 2026. The dividend yield is 2.66%.
Mochida Pharmaceutical Co., Ltd. is part of the Healthcare sector.
Mochida Pharmaceutical Co., Ltd. has a market cap of 613.72M EUR, based on the latest quote.
